Daniel Wolff

15.3k total citations · 3 hit papers
214 papers, 5.0k citations indexed

About

Daniel Wolff is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Daniel Wolff has authored 214 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Hematology, 56 papers in Oncology and 52 papers in Immunology. Recurrent topics in Daniel Wolff's work include Hematopoietic Stem Cell Transplantation (121 papers), T-cell and B-cell Immunology (26 papers) and Acute Myeloid Leukemia Research (20 papers). Daniel Wolff is often cited by papers focused on Hematopoietic Stem Cell Transplantation (121 papers), T-cell and B-cell Immunology (26 papers) and Acute Myeloid Leukemia Research (20 papers). Daniel Wolff collaborates with scholars based in Germany, Austria and United States. Daniel Wolff's co-authors include Ernst Holler, Hildegard Greinix, Ánita Lawitschka, Steven Z. Pavletic, Matthias Edinger, Daniela Weber, Wolfgang Herr, André Gessner, J. Hahn and Stephanie J. Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel Wolff

187 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

2014 367 citations Ernst Holler, Karin Schmid‐Zalaudek et al. profile →
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

2015 280 citations Daniel Wolff, Ánita Lawitschka et al. profile →
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

2018 266 citations Hélène Schoemans, James L.M. Ferrara et al. Bone Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Wolff Germany	35	2.9k	1.3k	1.3k	861	742	214	5.0k
Farid Boulad United States	37	2.5k 0.8×	2.0k 1.5×	1.5k 1.1×	814 0.9×	759 1.0×	167	5.7k
Annalisa Ruggeri France	38	3.3k 1.1×	1.5k 1.1×	1.3k 1.0×	684 0.8×	888 1.2×	207	5.6k
Peter A. McSweeney United States	44	3.9k 1.3×	1.6k 1.2×	1.7k 1.3×	845 1.0×	821 1.1×	143	6.3k
Hans A. Messner Canada	42	3.1k 1.1×	1.3k 1.0×	1.2k 0.9×	800 0.9×	819 1.1×	221	5.7k
Bronwen E. Shaw United States	38	3.6k 1.2×	1.2k 0.9×	1.7k 1.3×	402 0.5×	945 1.3×	225	5.2k
Takehiko Mori Japan	40	2.2k 0.8×	1.3k 1.0×	879 0.7×	384 0.4×	932 1.3×	303	5.0k
Robbert G. M. Bredius Netherlands	37	1.8k 0.6×	698 0.5×	1.8k 1.4×	721 0.8×	596 0.8×	128	4.3k
Montserrat Rovira Spain	44	2.5k 0.9×	2.1k 1.6×	1.0k 0.8×	668 0.8×	601 0.8×	218	6.7k
Douglas A. Stewart Canada	38	1.6k 0.5×	1.6k 1.2×	689 0.5×	784 0.9×	645 0.9×	208	4.8k
Ibrahim Yakoub‐Agha France	47	4.7k 1.6×	2.8k 2.2×	1.6k 1.3×	1.4k 1.6×	1.3k 1.7×	407	7.6k

Countries citing papers authored by Daniel Wolff

Since Specialization

Citations

This map shows the geographic impact of Daniel Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wolff more than expected).

Fields of papers citing papers by Daniel Wolff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wolff. The network helps show where Daniel Wolff may publish in the future.

Co-authorship network of co-authors of Daniel Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wolff. A scholar is included among the top collaborators of Daniel Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wolff. Daniel Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yaspo, Marie‐Laure, et al.. (2025). Treatment of SR/SD Chronic GvHD with In Vitro Expanded Donor Regulatory T Cells. Transplantation and Cellular Therapy. 31(2). S32–S32.

Wolff, Daniel, et al.. (2025). “ I can’t do it anymore”: a qualitative study on the emergence of crisis in outpatient palliative care—the perspective of family caregivers. BMC Palliative Care. 24(1). 39–39. 1 indexed citations

Halter, Jörg, Friedrich Stölzel, Markus Perl, et al.. (2025). Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. Bone Marrow Transplantation. 60(4). 439–446. 6 indexed citations

Wolff, Daniel, et al.. (2024). Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy. Annals of Hematology. 103(11). 4783–4787.

Perl, Markus, Dennis Christoph Harrer, Susanne Heimerl, et al.. (2024). Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies. Haematologica. 109(9). 2969–2977. 7 indexed citations

Penack, Olaf, Christophe Peczynski, Daniel Wolff, et al.. (2024). Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation. Haematologica. 109(11). 3557–3565. 5 indexed citations

Perl, Markus, Daniela Weber, Bernhard Banas, et al.. (2023). Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis. Transplantation and Cellular Therapy. 29(12). 772.e1–772.e10. 3 indexed citations

Koelbl, Oliver, Florian Zeman, Wolfgang Herr, et al.. (2023). Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia. Annals of Hematology. 102(8). 2199–2211. 1 indexed citations

Matos, Carina, Andreas Mamilos, Daniela Weber, et al.. (2022). Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation. Frontiers in Immunology. 13. 1028850–1028850. 7 indexed citations

10.

Harrer, Dennis Christoph, Matthias Fante, Robert Offner, et al.. (2022). Apheresis for chimeric antigen receptor T‐cell production in adult lymphoma patients. Transfusion. 62(8). 1602–1611. 13 indexed citations

11.

Harrer, Dennis Christoph, Felix Keil, Karin Menhart, et al.. (2022). Unusually swift response of relapsed Burkitt leukemia to R‐DHAP. SHILAP Revista de lepidopterología. 3(3). 1003–1008. 1 indexed citations

12.

Plentz, Annelie, et al.. (2021). Human bocavirus 1 respiratory tract reactivations or reinfections in two adults, contributing to neurological deficits and death. Access Microbiology. 3(7). 237–237. 3 indexed citations

13.

Wolff, Daniel, et al.. (2018). Paquita Baylina: uma trajetória musical esquecida no sul do Brasil. SHILAP Revista de lepidopterología. 3(2).

14.

Ullrich, Evelyn, Emilia Salzmann‐Manrique, Shahrzad Bakhtiar, et al.. (2016). Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation. Frontiers in Immunology. 7. 595–595. 33 indexed citations

15.

Mielke, Stephan, Mathias Lutz, Markus Kapp, et al.. (2014). Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis. Bone Marrow Transplantation. 49(11). 1412–1418. 13 indexed citations

16.

Holler, Ernst, Karin Schmid‐Zalaudek, Christian Hundsrucker, et al.. (2014). Metagenomic analysis of the stool microbiome in patients receiving allogeneic SCT: Loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal GvHD. University of Regensburg Publication Server (University of Regensburg). 4 indexed citations

17.

Hilgendorf, Inken, Mathias Freund, Wolfgang Jilg, et al.. (2011). Vaccination of allogeneic haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD. Vaccine. 29(16). 2825–2833. 65 indexed citations

18.

Beckers, M., et al.. (2011). Graft-versus-Host-Disease (GvHD) – ein Update. Der Hautarzt. 62(2). 139–155. 8 indexed citations

19.

Wolff, Daniel, et al.. (2010). O processo de digitacao para violao da Ciaccona BWV 1004 de Johann Sebastian Bach. SHILAP Revista de lepidopterología.

20.

Zaro, Milton Antônio, et al.. (2008). Metodologia para observação e quantificação de sinais de EEG relativos a evidências cognitivas de aprendizagem motora. 13(2). 27–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact